Live feed
Filing
SC 13G/A
SC 13G/A0001085146-17-000432·Correvio Pharma Corp.
Schedule 13G ownership disclosure
CARDIOME PHARMA CORP
Security class unavailable · CUSIP: 14159U301
Event date: 2016-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,078,393
- Percent of class
- 15.9300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-17-000432
- Form type
- SC 13G/A
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Feb 10, 2017
- Reporting period
- Dec 30, 2016
- Description
- Schedule 13G beneficial ownership